GM‐CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid‐derived suppressor cells <i>in vitro</i>
Tessa Gargett(South Australia Pathology), Michael P. Brown(South Australia Pathology), Susan N. Christo(The University of Melbourne), M. Nazim Abbas(Royal Adelaide Hospital), Angel F. López(Centre for Cancer Biology), Timothy R. Hercus(South Australia Pathology), Nimit Singhal(Royal Adelaide Hospital)
Cited by 36
Related Papers
The inducible caspase-9 suicide gene system as a “safety switch†to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
|Frontiers in Pharmacology|2014|390
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
|The Lancet Oncology|2021|389
GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade
|Molecular Therapy|2016|358
Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses
|Nature Immunology|2018|324
Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
|Nature Immunology|2021|228